Delivery Order SPE2DB22D1017-SPE2DB24FG2QK

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sirolimus 1 mg/ml solution in 60 ml containers. The contract has a firm-fixed price of $2,432.75 and an ultimate completion date of May 28, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $4,196.80 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. AmerisourceBergen was awarded the delivery order to provide Sirolimus 1 mg/ml solution, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen, valued up to $999,999,999.00...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 tablets of the pharmaceutical product SIROLIMUS 2 MG. The $2,080.06 order has a completion date of December 22, 2023 and was placed without the use of a set-aside. Amerisourcebergen Drug Corp, through its Corporate Office division, has extensive experience as a prime contractor supplying pharmaceuticals, medical...
This federal contract award, SPE2DX15D1053|SPE2DX24F6NJU, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,491.65 firm fixed-price delivery order is for the provision of 100 tablets of the drug Sirolimus 1 mg. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Everolimus 10 mg tablets. The award has a ceiling value of $6,791.30 and a completion date of June 11, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Everolimus 1 mg tablets. The contract is valued at $1,294.85 and has an ultimate completion date of August 29, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts to provide a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Everolimus 10 mg tablets. The contract, valued at $1,360.76, runs through September 14, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,927.99 firm fixed-price contract is for the delivery of Everolimus 10 mg tablets, a medication used to treat certain medical conditions. The contract has an ultimate completion date of April 18, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Everolimus 0.5 mg tablets, a medication used for various medical conditions. The contract has a firm fixed price of $15,880.66 and a completion date of September 12, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,244.68 firm fixed-price delivery order is for the supply of Everolimus 5 mg tablets in 28-count units. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG2QK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Sirolimus 0.5 mg tablets. The firm-fixed-price contract has a ceiling value of $1,484.45 and a completion date of August 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs, from AmerisourceBergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/4/24, 9:14 AM